Literature DB >> 8107021

Effects of tamoxifen on the fertility of male rats.

M K Gill-Sharma1, K Gopalkrishnan, N Balasinor, P Parte, S Jayaraman, H S Juneja.   

Abstract

The effects of oral administration of tamoxifen (a synthetic non-steroidal anti-oestrogen) at doses of 40, 200 or 400 micrograms kg-1 day-1 on the circulating concentrations of LH, FSH, prolactin, testosterone and oestradiol, weights of pituitary, testes, secondary sex organs and the fertility of adult male rats were determined. The drug was administered per os daily, for up to 90 days. The fertility of rats treated with tamoxifen for 60, 70, 80 or 90 days was assessed by allowing them to mate with normal female rats of proven fertility. Tamoxifen at 40 micrograms kg-1 day-1 reduced concentrations of testosterone in plasma but had no affect on LH, FSH, prolactin and oestradiol concentrations, and the weights of pituitary, testes, epididymides, ventral prostate and seminal vesicles. Tamoxifen at 40 micrograms kg-1 day-1 reduced potency, fecundity, the number of implantation sites, the fertility index and litter size. Tamoxifen at 200 and 400 micrograms kg-1 day-1 reduced the concentrations of LH and testosterone in plasma and the weights of testes and secondary sex organs compared with controls. Tamoxifen at 400 micrograms kg-1 day-1 was most effective in reducing the number of viable pups, the litter size (< or = 1) and the fecundity (20%). The potency of treated rats (a measure of the presence of an ejaculate) was significantly decreased when compared with controls, but copulation was apparently not affected as mated female rats showed a constant dioestrous phase. Histology of the testes revealed disorganization of the cytoarchitecture of the tubules with obliterated lumen.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8107021     DOI: 10.1530/jrf.0.0990395

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  8 in total

1.  Antifertility effects of estradiol in adult male rats.

Authors:  M K Gill-Sharma; S Dsouza; V Padwal; N Balasinor; M Aleem; P Parte; H S Juneja
Journal:  J Endocrinol Invest       Date:  2001-09       Impact factor: 4.256

2.  Estrogen signaling, through estrogen receptor β, regulates DNA methylation and its machinery in male germ line in adult rats.

Authors:  Kushaan Dumasia; Anita Kumar; Sharvari Deshpande; Nafisa H Balasinor
Journal:  Epigenetics       Date:  2017-03-31       Impact factor: 4.528

Review 3.  Oestrogens and spermatogenesis.

Authors:  Serge Carreau; Rex A Hess
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-05-27       Impact factor: 6.237

4.  Mechanism delineating differential effect of an antiestrogen, tamoxifen, on the serum LH and FSH in adult male rats.

Authors:  N Balasinor; P Parte; M K Gill-Sharma; J Kini; H S Juneja
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

5.  Estrogen receptor, calcium mobilization and rat sperm motility.

Authors:  G Sethi Saberwal; M K Sharma; N Balasinor; J Choudhary; H S Juneja
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

6.  Antifertility effects of fluphenazine in adult male rats.

Authors:  M K Gill-Sharma; M Aleem; G Sethi; J Choudhary; V Padwal; S D'Souza; N Balasinor; P Parte; H S Juneja
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

7.  Relationship between expression of sex steroid receptors and structure of the seminal vesicles after neonatal treatment of rats with potent or weak estrogens.

Authors:  K Williams; J S Fisher; K J Turner; C McKinnell; P T Saunders; R M Sharpe
Journal:  Environ Health Perspect       Date:  2001-12       Impact factor: 9.031

8.  Low-dose tamoxifen treatment in juvenile males has long-term adverse effects on the reproductive system: implications for inducible transgenics.

Authors:  Saloni H Patel; Laura O'Hara; Nina Atanassova; Sarah E Smith; Michael K Curley; Diane Rebourcet; Annalucia L Darbey; Anne-Louise Gannon; Richard M Sharpe; Lee B Smith
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.